84 results
425
EX-2.1
LAB
Standard BioTools Inc.
4 Oct 23
Business combination disclosure
8:13am
(a)
PPACA
Section 3.13(i)
Pre-Closing Period
Section 5.1
Recall
Section 3.18(e)
Recipient
Section 7.9(a)
Registration Statement
Section 5.4
Representatives … ) (collectively “Recall”). Neither the Company, nor, to the Company’s Knowledge, any Governmental Entity or other Person, has sought, is seeking
8-K
EX-2.1
LAB
Standard BioTools Inc.
4 Oct 23
Standard BioTools and SomaLogic to Combine in All-Stock Merger
8:08am
(a)
PPACA
Section 3.13(i)
Pre-Closing Period
Section 5.1
Recall
Section 3.18(e)
Recipient
Section 7.9(a)
Registration Statement
Section 5.4
Representatives … ) (collectively “Recall”). Neither the Company, nor, to the Company’s Knowledge, any Governmental Entity or other Person, has sought, is seeking
PRE 14A
gptm9
11 Feb 22
Preliminary proxy
9:31pm
DEFA14A
3kytigk0e7uhw zx
24 Jan 22
Additional proxy soliciting materials
5:27pm
8-K
EX-10.4
raqi5y7 3w
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-10.3
k6qk5k6bb hvuu4bs2
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
424B5
zen v3ox88
5 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
fzkd11z3j6a0l70pw
4 Mar 20
Entry into a Material Definitive Agreement
9:41pm